PARIS: Global coronavirus infections passed 65 million on Friday and countries doubled down on restrictions, even as plans to roll out vaccines gathered pace.
Pfizer, BioNTech Shares Ripe for a Bumpy Ride Ahead of Key Panel
Copyright 2020 NPR. To see more, visit https://www.npr.org. STEVE INSKEEP, HOST: OK. Now, once a vaccine is approved and states begin getting their
Luxury brand Gucci, owned by French group Kering, will give at least $500,000 (371,333 pounds) to UNICEF to help supply and distribute COVID-19 vaccines to vulnerable...
COVAX has so far raised $2 billion
(WIVB)– Health care workers and nursing home residents are going to be the first in line to receive the vaccine. Stephen Hanse is the president and...
Researchers have developed a novel insulin molecule that responds to glucose levels in the blood sugar of rats.
Department of Biotechnology secretary Renu Swarup said the vaccines that are being developed indigenously are on different platforms and each has its own benefits...
By DR. SHIELA BEROUKHIM AFRAHIMI, ABC News
Although front-runner COVID-19vaccines from Pfizer and Moderna boast efficacy rates of greater than 90%, scientists say it is crucial to continue to study new vaccines, which...